Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)-Reference-Cited by-同舟云学术

Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)

Published:2015-06-19 Issue:8 Volume:28 Page:1101-1122
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

McCluggage W Glenn,Judge Meagan J,Clarke Blaise A,Davidson Ben,Gilks C Blake,Hollema Harry,Ledermann Jonathan A,Matias-Guiu Xavier,Mikami Yoshiki,Stewart Colin JR,Vang Russell,Hirschowitz Lynn

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol201577.pdf

Reference164 articles.

1. Kench J, Delahunt B, Griffiths DF et al. Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting. Histopathology 2013;62:203–218.

2. McCluggage WG, Colgan T, Duggan M et al. Data Set for Reporting of Endometrial Carcinomas: Recommendations From the International Collaboration on Cancer Reporting (ICCR) Between United Kingdom, United States, Canada, and Australasia. Int J Gynecol Pathol 2012;32:45–65.

3. Scolyer RA, Judge MJ, Evans A et al. Data set for pathology reporting of cutaneous invasive melanoma recommendations from the International Collaboration on Cancer Reporting (ICCR). Am J Surg Pathol 2013;37:1797–1814.

4. Jones KD, Churg A, Henderson DW et al. Data set for reporting of lung carcinomas: recommendations from International Collaboration on Cancer Reporting. Arch Pathol Lab Med 2013;137:1054–1062.

5. Prat J, FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 2014;124:1–5.

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathological PCI as a prognostic marker of survival after neoadjuvant chemotherapy in patients undergoing interval cytoreduction with or without HIPEC in FIGO stage IIIC high grade serous ovarian cancer;Frontiers in Oncology;2024-08-20

2. Limitations of homologous recombination status testing and poly (ADP-ribose) polymerase inhibitor treatment in the current management of ovarian cancer;Frontiers in Oncology;2024-07-22

3. The impact of Paclitaxel-based hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer patients - interim analysis of safety and immediate efficacy of a randomized control trial (C-HOC trial);Journal of Ovarian Research;2024-07-12

4. Endometrioid carcinoma of the fallopian tube misdiagnosed as an infected endometrioma: A case report;International Journal of Surgery Case Reports;2024-07

5. Chemotherapy response score as a predictor of survival in ovarian cancer patients;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-05